Total liabilities · 2011–2025
Neurocrine Biosciences total liabilities
$1.4B+22.1% · FY2025
Neurocrine Biosciences (NBIX) reported $1.4B in total liabilities for fiscal 2025, +22.1% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.4B | +22.1% | Open → |
| FY20242024-12-31 | $1.1B | +10.8% | Open → |
| FY20232023-12-31 | $1.0B | +54.2% | Open → |
| FY20222022-12-31 | $661M | −5.4% | Open → |
| FY20212021-12-31 | $699M | +14.8% | Open → |
| FY20202020-12-31 | $609M | −9.1% | Open → |
| FY20192019-12-31 | $669M | +30.6% | Open → |
| FY20182018-12-31 | $512M | +15.0% | Open → |
| FY20172017-12-31 | $445M | +787.2% | Open → |
| FY20162016-12-31 | $50.2M | −0.2% | Open → |
| FY20152015-12-31 | $50.3M | +46.6% | Open → |
| FY20142014-12-31 | $34.3M | +0.2% | Open → |
| FY20132013-12-31 | $34.3M | −17.6% | Open → |
| FY20122012-12-31 | $41.6M | −46.9% | Open → |
| FY20112011-12-31 | $78.3M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +22.7%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Neurocrine Biosciences total liabilities |url=https://companiesranked.com/en/company/neurocrine-biosciences/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Neurocrine Biosciences total liabilities. CompaniesRanked. https://companiesranked.com/en/company/neurocrine-biosciences/total-liabilitiesBibTeX
@misc{companiesranked-en-company-neurocrine-biosciences-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Neurocrine Biosciences total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/neurocrine-biosciences/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000914475-26-000037 · July 31, 2026
{{cite web |title=Neurocrine Biosciences total liabilities — 10-Q (0000914475-26-000037) |url=https://www.sec.gov/Archives/edgar/data/914475/000091447526000037/nbix-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-31}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.